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H yperhomocysteinemia (hHcys) has been recognized as an important independent risk factor in the progression of end-stage renal disease and in the development of cardiovascular complications related to end-stage renal disease. 1, 2 Recent studies have demonstrated that homocysteine (Hcys) may directly act on glomerular cells to induce glomerular dysfunction and consequent glomerulosclerosis, leading to end-stage renal disease. [3] [4] [5] [6] However, so far there are no efficient Hcys-lowering and Hcys-detoxifying strategies being used in patients with cardiovascular and chronic kidney disease. 7, 8 Therefore, the key targets in the pathogenic pathways for Hcys-induced renal injury should be identified to direct toward prevention or treatment of end-stage renal disease associated with hHcys. Although several mechanisms are involved in the pathogenesis of hHcys, such as oxidative stress, endoplasmic reticulum stress, and inflammation, 1 the mechanisms triggering the pathogenic actions of hHcys are not yet fully understood.
Nucleotide-binding oligomerization domain containing 2 (NOD2), a member of the NOD-like receptor family, plays an important role in innate immune and adaptive response. Studies have revealed the association of NOD2 with several pathologies, including Crohn disease, atherosclerosis, and Alzheimer disease. 9 In addition to being present in inflammatory cells, studies from our laboratory and by others have indicated that NOD2 is also highly expressed in the kidney, 10 including renal proximal tubule epithelial cells, 11 glomerular mesangial cells, endothelial cells, and podocytes. 12 The expression within renal cells may position this innate intracellular protein as a sentinel participant in response to endogenous danger signals associated with renal disease. An elevated level of Hcys has been demonstrated to induce chronic inflammation in the vascular bed, including glomerulus. 13, 14 However, it remains unknown whether NOD2-mediated signaling in renal glomerular residential cells contributes to the pathogenesis of renal injury in hHcys.
Abstract-Although hyperhomocysteinemia (hHcys) has been recognized as an important independent risk factor in the progression of end-stage renal disease and in the development of cardiovascular complications related to end-stage renal disease, the mechanisms triggering the pathogenic actions of hHcys are not yet fully understood. The present study was designed to investigate the contribution of nucleotide-binding oligomerization domain containing 2 (NOD2), an intracellular innate immunity mediator, to the development of glomerulosclerosis in hHcys. Our results showed that NOD2 deficiency ameliorated renal injury in mice with hHcys. We further discovered the novel role of NOD2 in mediating Ca 2+ signaling and found that homocysteine-induced NOD2 expression enhanced transient receptor potential cation channel 6 (TRPC6) expression and TRPC6-mediated calcium influx and currents, leading to intracellular Ca 2+ release, ultimately resulting in podocyte cytoskeleton rearrangement and apoptosis. Moreover, we found that nephrin expression was downregulated dependently by NOD2, and overexpression of nephrin attenuated homocysteine-induced TRPC6 expression in podocytes. The results add evidence to support the essential role of nephrin in mediating NOD2-induced TRPC6 expression in hHcys. In conclusion, our results for the first time establish a previously unknown function of NOD2 for the regulation of TRPC6 channels, suggesting that TRPC6-dependent Ca 2+ signaling is one of the critical signal transduction pathways that links innate immunity mediator NOD2 to podocyte injury. Pharmacological targeting of NOD2 signaling pathways at multiple levels may help design a new approach to develop therapeutic strategies for 2
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Podocytes are unique terminally differentiated epithelial cells in the filtration barrier of the kidney; loss of podocyte functions is considered as an early and key event in the development of glomerulosclerosis. 15, 16 However, it remains unclear whether NOD2 is associated with changes in podocyte structure and functions in hHcys. Our study showed that NOD2 deficiency ameliorated renal injury in mice with hHcys. We further discovered the novel role of NOD2 in mediating Ca 2+ signaling and demonstrated that NOD2-mediated transient receptor potential cation channel 6 (TRPC6) expression and activity via nephrin, which lead to intracellular Ca 2+ release, ultimately result in podocyte dysfunction, suggesting that TRPC6-dependent Ca 2+ signaling is one of the critical signal transduction pathways that links innate immunity mediator NOD2 to podocyte injury.
Materials and Methods
An extended Material and Methods section can be found in the online-only Data Supplement.
Animals
Twelve-week-old NOD2 −/− mice were purchased from the Jackson Laboratory (Bar Harbor, ME).
Immunofluorescence
Immunofluorescent staining was performed as described 17 using a LSM780 laser scanning confocal microscope (ZEISS, Oberkochen, Germany) equipped with a Plan-Apochromat 63×/1.4 objective.
Electrophysiological Analysis
The procedures for cell-attached patch-clamp recordings of TRPC6 channel currents from podocytes are presented in the online-only data Supplement.
Statistics
Data are expressed as mean±SE. The significance of the differences in mean values between and within multiple groups was examined by 1-way ANOVA followed by Duncan multiple range test. P<0.05 was considered statistically significant.
Results

NOD2 Deficiency Ameliorated Renal Injury and Reduced TRPC6 Expression in Mice With hHcys
Our studies indicated that NOD2 expression was significantly increased in the kidney from hHcys-induced mice by folatefree diets ( Figure 1A ). Therefore, NOD2
−/− mice were used to explore the role of NOD2 in the pathogenesis of hHcys. Our results showed that although plasma total Hcys levels were increased as the same levels of wild-type mice with folate-free diets (plasma total Hcys level >10 μmol/L is considered as hHcys; Figure 1B ), albuminuria ( Figure 1C ) was significantly less in NOD2 −/− mice with hHcys accompanied by decreased mesangial expansion ( Figure 1D ) and ameliorated podocyte injury ( Figure 1E ) compared with those of wild-type mice with hHcys. Meanwhile, NOD2 deficiency decreased the levels of proinflammatory mediators, including interleukin-1β, interleukin-6, tumor necrosis factor-α, monocyte chemoattractant protein-1, and intracellular adhesion molecule-1 in hHcys ( Figure 1F ). Moreover, Western blot ( Figure 1G ) and immunofluorescence ( Figure 1H ) analyses indicated that hHcys-induced TRPC6 expression was attenuated by NOD2 deficiency.
Hcys-Induced TRPC6 Expression Was Mediated by NOD2 in Podocytes
As shown in Figure 2A , Hcys enhanced NOD2 and TRPC6 expression in podocytes. Activation of NOD2 by muramyl dipeptide (MDP) also induced TRPC6 expression ( Figure 2B ). We further found that gene silencing of NOD2 by shRNA-NOD2 transfection ( Figure 2C ) blocked Hcys-induced TRPC6 expression ( Figure 2D ).
NOD2 Was Required for Hcys-Mediated Ca 2+ Influx and Currents via TRPC6 in Podocytes
To confirm the contribution of NOD2 to Hcys-mediated Ca 2+ influx, we evaluated Ca 2+ influx into fluo-2-loaded podocytes stimulated by 1-oleoyl-2-acetyl-sn-glycerol, a TRPC6 channel agonist. It was found that Hcys enhanced 1-oleoyl-2-acetyl-sn-glycerol-stimulated Ca 2+ influx, which was attenuated by NOD2 knockdown ( Figure 3A) . Consistently, application of 1-oleoyl-2-acetyl-sn-glycerol caused increased cation currents in podocytes. Moreover, the currents were substantially larger in podocytes with MDP or Hcys treatment, which were attenuated by NOD2 knockdown ( Figure 3B ).
NOD2-Mediated TRPC6 Channels Was Associated With Cytoskeleton Rearrangement and Apoptosis in Podocytes
As shown in Figure S1A in the online-only Data Supplement, MDP or Hcys altered cytoskeleton distribution as evidenced by the loss of actin filaments and a granular cytoplasmic pattern of actin distribution. Consistent with the effects of TRPC6 knockdown, the disruption of actin was dramatically ameliorated by NOD2 knockdown in Hcys-treated podocytes. Furthermore, flow cytometric analysis indicated that both Hcys and MDP induced podocyte apoptosis, which was inhibited by gene silencing of NOD2 or TRPC6 ( Figure S1B ).
TRPC6 Expression Was Associated With NOD2-Reduced Nephrin Expression in hHcys
We found that both Hcys ( Figure 4A ) and MDP ( Figure 4B ) decreased nephrin expression in podocytes. Further studies showed that overexpression of nephrin by pcDNA3.1-NPHS1 transfection ( Figure 4C ) attenuated Hcys-induced TRPC6 expression ( Figure 4D ). These results were consistent with in vivo study showing that decreased nephrin expression was recovered in NOD2 −/− mice with hHcys ( Figure S2 ).
Discussion
Among pattern-recognition receptors, the intracellular NODlike receptors have recently been identified as key mediators of inflammatory and immune responses. 9, 18 The crucial role of NOD2, a member of the NOD-like receptor family, in inflammatory homeostasis is underscored by the observation that mutations in the NOD2 gene are associated with susceptibility to Crohn disease and Blau syndrome. 19 This study was to investigate whether NOD2 contributes to renal injury in hHcys. We produced experimental hHcys by feeding mice with folate-free diets. Our results showed folate-free diets induced NOD2 expression. Furthermore, we found that NOD2 deficiency ameliorated hHcys-induced albuminuria, podocyte injury, and glomerulosclerosis, indicating that NOD2 is an important element triggering renal injury in hHcys.
In this study, one of the most important findings is that we discovered a novel function of NOD2 in mediating TRPC6-dependent Ca 2+ signaling in podocytes. Changes in podocyte function and structure are of pathogenetic relevance to human proteinuric kidney diseases. 20 Several podocyte-associated proteins, including nephrin, podocin, and TRPC6, have emerged to provide critical insight into the pathogenesis of nephrotic syndromes. [21] [22] [23] The discovery that gain-of-function mutations in the TRPC6 channel form a subset of familial forms of focal segmental glomerulosclerosis has focused attention on the basic cellular physiology of podocytes. In addition, elevated expression levels of TRPC6 in the podocyte slit diaphragm have been identified to cause podocyte injury and human renal diseases, such as minimal-change disease and membranous glomerulonephritis, suggesting that TRPC6 also plays a pivotal role in nongenetic forms of glomerular disease. 22 Here, we found that TRPC6 expression was enhanced in the kidney from mice with hHcys, which was attenuated by NOD2 deficiency, indicating the role of NOD2 on the regulation of TRPC6 in hHcys.
As a Ca overload through, at least in part, NOD2-mediated TRPC6 expression and activity. We further demonstrated that NOD2 was associated with changes in cytoskeleton distribution and podocyte apoptosis via TRPC6.
Nephrin is essential for the maintenance of podocyte integrity; mutations in this gene cause the most severe form of congenital nephrotic syndrome. 24, 25 Although acting as an adhesion molecule, nephrin is a pivotal regulator of podocyte intracellular signaling, 26 which is important in downstream Phosphatidylinositide 3-kinase signaling and a negative regulator of nuclear factor-κB activity. TRPC6 interactions with nephrin near the slit diaphragm may underlie regulation of gating and trafficking of these channels and studies have reported that nephrin plays a role in modulating TRPC6 channel opening. 22 Moreover, the absence of nephrin as shown in neonatal nephrin −/− mice led to increased expression of TRPC6 in podocytes compared with podocytes of wild-type littermates. 22, 23 Considering our previous study showing that activation of NOD2 reduced nephrin expression, it would be of great interest to elucidate whether NOD2-mediated nephrin expression contributes to the regulation of TRPC6 channel. In this study, reduced nephrin expression was observed in the kidney from mice with hHcys, and nephrin expression could be partially recovered accompanied by reduced TRPC6 expression in NOD2 −/− mice with hHcys. To further confirm the contribution of NOD2-nephrin signaling to the regulation of TRPC6 expression, we studied NOD2 and TRPC6 in cultured podocytes. In vitro, we found that nephrin expression was dependently regulated by NOD2. Furthermore, overexpression of nephrin attenuated Hcysinduced TRPC6 expression. The results add further evidence to support the essential role of nephrin in mediating NOD2-induced TRPC6 expression in Hcys-treated podocytes.
In this study, although we focus on the role of NOD2 in mediating Ca 2+ signaling in podocytes, we cannot exclude that NOD2 in infiltration of immune cells or other renal residential cells also plays an important role in hHcys-induced renal injury. NOD2 in inflammatory cells may induce the activation of nuclear factor-κB and trigger a cell signaling cascade mediated by the stress-activated protein kinases, leading to the increase in the production of proinflammatory mediators. The renal residential cells then respond by these signaling molecules, ultimately resulting in renal injury. In addition, TRPC channels have been reported to be associated with the production of proinflammatory cytokines and inflammation. 27, 28 A very recent study has demonstrated that TLR4 activation of TRPC6-dependent Ca 2+ signaling mediates endotoxin-induced lung vascular permeability and inflammation. 27 Strikingly, except NOD2-mediated Ca 2+ signaling directly contributing to cytoskeleton rearrangement and podocyte apoptosis, our preliminary results indicate that knockdown of TRPC6 can also attenuate NOD2-induced production of proinflammatory mediators in podocytes (data not shown). Therefore, it is very possible that NOD2-mediated Ca 2+ signaling and its proinflammatory action may build a signaling network to modulate related signaling in producing renal injury in hHcys.
Further detailed studies are required to pinpoint the precise mechanisms both in vitro and in vivo.
It should be noted that the current studies suggest a direct causal link between NOD2 and TRPC6 in podocytes.
However, we cannot rule out the involvement of other glomerular components and cannot avoid that all cells in the body are affected by systemic NOD2 deletion, which can lead to complex phenotypes that confound interpretation. Therefore, a podocyte-specific knockout of NOD2 mice may be needed to further confirm the current findings. 
Perspectives
The current findings add an additional downstream pathway to NOD2 signaling and establish a previously unknown function of NOD2 in mediating Ca 2+ signaling, suggesting that TRPC6-dependent Ca 2+ signaling is one of the critical signal transduction pathways that links innate immunity mediator NOD2 to podocyte injury in hHcys. In addition, TRPC6 has been linked to hypertension, cardiac hypertrophy, cardiac fibrosis, and neuronal degeneration. Therefore, pharmacological targeting of NOD2-mediated Ca 2+ signaling pathways via TRPC6 at multiple levels may help design a new approach to develop therapeutic strategies for prevention of deterioration of kidney function and for the treatment of hHcys-associated end-organ damage.
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What Is New?
• The present study discovered a previously unknown function of nucleotide-binding oligomerization domain containing 2 (NOD2) in mediating Ca 2+ signaling, suggesting that transient receptor potential cation channel 6-dependent Ca 2+ signaling is one of critical signal transduction pathways that links innate immunity mediator NOD2 to podocyte injury.
What Is Relevant?
• Except for the role of NOD2 in innate immune and adaptive response, NOD2-mediated transient receptor potential cation channel 6 expression and activity importantly contribute to the initiation and development of glomerulosclerosis. This finding underlines the crucial role of NOD2 in the pathogenesis of podocyte injury and proteinuria. Summary NOD2-triggered transient receptor potential cation channel 6-mediated Ca 2+ signaling is an early pathogenic event of podocyte injury, and the development of strategies that target the activation of podocyte NOD2 may be a promising therapeutic intervention to prevent hyperhomocysteinemia-associated end-stage renal disease. Representative confocal microscopic images showing nephrin expression in glomeruli from different group of mice with hHcys, synaptopodin was used as podocyte marker. B. Representative Western blot gel documents and summarized data showing that decreased nephrin expression was recovered in NOD2 -/-mice with hHcys.*P<0.05 vs. control, # P<0.05 vs. WT mice with hHcys (n=10).
